| Tag | Content |
|---|
EnhancerAtlas ID | HS105-52985 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr22:32072550-32073220 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF5 | MA0599.1 | chr22:32072862-32072872 | GCCCCGCCCC | + | 6.02 | | NFYA | MA0060.3 | chr22:32072885-32072896 | AGCCAATCAGA | + | 6.32 | | USF1 | MA0093.2 | chr22:32072777-32072788 | ACCACGTGACC | + | 6.32 | | USF2 | MA0526.2 | chr22:32072775-32072791 | TAACCACGTGACCCTC | - | 6.33 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_10007 | chr22:32072142-32073464 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I031676 | chr22 | 32072188 | 32073393 |
|
Enhancer Sequence | CGGCTCACGG CACCTACAGT CTCCCGAGTT CAAGCGATTC TTCTGCCTCA GCTTCCCGAG 60
TAGCTGGGAT TACAGGCGCG CGCCACCACT CCCGGCTAAT TTTTTGTATT TTTAGTAGAG 120
TCACCAGGTT GGCCAGGCCT GTCTCAAGTG ATCCGCCCGC CTCTGCCTCC CAAAGTGCTG 180
GGATTACAGG CTTGAGTCAC CGCGCCCGGC CCACGTGGCG AGTCTTAACC ACGTGACCCT 240
CCCCGCTCTC CAGCCCGGCA GGTACCAGCA AAGGACTAGC AGCCTCCTCC AATATGGATA 300
GCTTCTCGGA TGGCCCCGCC CCTCCGGAGA GCTGCAGCCA ATCAGACGGC GTGAGGCCAG 360
CAGTGGGTGC GGCTGCGCTT GGCGCTGCGC ATATCCGAAT ACCAGGAAGT GCCCGGTTTC 420
GCTGTCAGTG CTCGGGCAGC TAGAATCCAG GTCCCTTGAG GAATAATTTA AGAAGGGGTG 480
GAGAAAAATT AGGGGGCGTC TTCAAATATT CAGAGAGTCA GCGAGGTAAA GAGGACTTGG 540
GCAGGTCTGT GTAGCAACGG GGGCGGGAAT CATTCATTGA CGCATGAAGT ATTTCCTGAG 600
CTCCCACCAC GTAAGACCAA GTTTTGTTCT AGATGTCCGA GGGGCCAGAG TGAATATAGC 660
AAAGTCTTTG 670
|
